Based on 15 analysts giving stock ratings to Perspective Therapeutics Inc in the past month.
In the current month, CATX has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CATX average Analyst price target in the last month is 10.571.
Based on analysts' estimates, CATX EPS is projected to reach -0.259 in FY2026Q4, following reported EPS of -0.269 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.27, while Perspective Therapeutics IncCATX's earnings per share (EPS) for the previous quarter was USD -0.22. EPS for the next quarter is expected at USD -0.26.